UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies

Clinical cancer research, 2020-03, Vol.26 (5), p.1025-1033

2020

Volltextzugriff (PDF)

Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production

Scientific reports, 2021-08, Vol.11 (1), p.16347-16347, Article 16347

2021

Volltextzugriff (PDF)

Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer

Oncoimmunology, 2021-01, Vol.10 (1), p.1900635-1900635

2021

Volltextzugriff (PDF)

Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma

Cancer research (Chicago, Ill.), 2018-11, Vol.78 (21), p.6308-6319

2018

Volltextzugriff (PDF)

Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responses

Science translational medicine, 2012-06, Vol.4 (137), p.137ra74

2012

Volltextzugriff (PDF)

Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy

Oncotarget, 2016-11, Vol.7 (48), p.78653-78666

2016

Volltextzugriff (PDF)

The Dynamic Entropy of Tumor Immune Infiltrates: The Impact of Recirculation, Antigen-Specific Interactions, and Retention on T Cells in Tumors

Frontiers in oncology, 2021-04, Vol.11, p.653625-653625

2021

Volltextzugriff (PDF)

Using Preclinical Data to Design Combination Clinical Trials of Radiation Therapy and Immunotherapy

Seminars in radiation oncology, 2020-04, Vol.30 (2), p.158-172

2020

Volltextzugriff (PDF)

Clinical Development of Novel Drug-Radiotherapy Combinations

Clinical cancer research, 2019-03, Vol.25 (5), p.1455-1461

2019

Volltextzugriff (PDF)

A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity

PloS one, 2019-01, Vol.14 (1), p.e0209153-e0209153

2019

Volltextzugriff (PDF)

STING expression and response to treatment with STING ligands in premalignant and malignant disease

PloS one, 2017-11, Vol.12 (11), p.e0187532-e0187532

2017

Volltextzugriff (PDF)

Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma

Journal for immunotherapy of cancer, 2021-05, Vol.9 (5), p.e002485

2021

Volltextzugriff (PDF)

Abstract IA-013: Integrating radiation therapy with immunotherapy

Clinical cancer research, 2021-04, Vol.27 (8_Supplement), p.IA-013-IA-013

Crittenden, Marka

2021

Volltextzugriff (PDF)

Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease

PloS one, 2018-02, Vol.13 (2), p.e0192988-e0192988

2018

Volltextzugriff (PDF)

Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade

Science translational medicine, 2024-09, Vol.16 (765), p.eadk0642

2024

Volltextzugriff (PDF)

A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma

Journal for immunotherapy of cancer, 2016-08, Vol.4 (1), p.45-45, Article 45

2016

Volltextzugriff (PDF)

Expression of arginase I in myeloid cells limits control of residual disease after radiation therapy of tumors in mice

Radiation research, 2014-08, Vol.182 (2), p.182-190

2014

Volltextzugriff (PDF)

Amplifying IFN-γ Signaling in Dendritic Cells by CD11c-Specific Loss of SOCS1 Increases Innate Immunity to Infection while Decreasing Adaptive Immunity

The Journal of immunology (1950), 2018-01, Vol.200 (1), p.177-185

2018

Volltextzugriff (PDF)

OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironment

Oral oncology, 2016-01, Vol.52, p.1-10

2016

Volltextzugriff (PDF)

Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice

Journal of immunotherapy, 2010-10, Vol.33 (8), p.798-809

2010

Volltextzugriff (PDF)

Transoral robotic surgery and neck dissection for HPV-positive oropharyngeal carcinoma: Importance of nodal count in survival

Oral oncology, 2020-10, Vol.109, p.104770, Article 104770

2020

Volltextzugriff (PDF)

Ex vivo analysis of radiation effects on tumor infiltrating immune cells using tumor explants

Methods in cell biology, 2023, Vol.174, p.55-63

2023

Volltextzugriff (PDF)

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection

Oncotarget, 2021-06, Vol.12 (13), p.1201-1213

2021

Volltextzugriff (PDF)

Systemic immunostimulation induces glucocorticoid-mediated thymic involution succeeded by rebound hyperplasia which is impaired in aged recipients

Frontiers in immunology, 2024-09, Vol.15, p.1429912

2024

Volltextzugriff (PDF)

Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy

Oral oncology, 2016-10, Vol.61, p.166-176

2016

Volltextzugriff (PDF)

26 – 50 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(130)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(132)
Buchkapitel
(2)

Sprache

Englisch
(134)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies

Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production

Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer

Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma

Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responses

Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy

The Dynamic Entropy of Tumor Immune Infiltrates: The Impact of Recirculation, Antigen-Specific Interactions, and Retention on T Cells in Tumors

Using Preclinical Data to Design Combination Clinical Trials of Radiation Therapy and Immunotherapy

Clinical Development of Novel Drug-Radiotherapy Combinations

A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity

STING expression and response to treatment with STING ligands in premalignant and malignant disease

Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma

Abstract IA-013: Integrating radiation therapy with immunotherapy

Correction: STING expression and response to treatment with STING ligands in premalignant and malignant disease

Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade

A hypofractionated radiation regimen avoids the lymphopenia associated with neoadjuvant chemoradiation therapy of borderline resectable and locally advanced pancreatic adenocarcinoma

Expression of arginase I in myeloid cells limits control of residual disease after radiation therapy of tumors in mice

Amplifying IFN-γ Signaling in Dendritic Cells by CD11c-Specific Loss of SOCS1 Increases Innate Immunity to Infection while Decreasing Adaptive Immunity

OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironment

Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice

Transoral robotic surgery and neck dissection for HPV-positive oropharyngeal carcinoma: Importance of nodal count in survival

Ex vivo analysis of radiation effects on tumor infiltrating immune cells using tumor explants

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection

Systemic immunostimulation induces glucocorticoid-mediated thymic involution succeeded by rebound hyperplasia which is impaired in aged recipients

Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy

Suchergebnisse filtern